{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05737485",
            "orgStudyIdInfo": {
                "id": "RCT1100-101"
            },
            "organization": {
                "fullName": "ReCode Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects",
            "officialTitle": "A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study, in Healthy Adult Participants and Open-Label Single Ascending Dose Study in Adults With Primary Ciliary Dyskinesia Caused by Pathogenic Mutations in the DNAI1 Gene to Evaluate the Safety and Tolerability of RCT1100",
            "therapeuticArea": [
                "Dermatology"
            ],
            "study": "study-evaluating-the-safety-and-tolerability-of-in-healthy-and-pcd-subjects"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-02-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09-21",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-21",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-01-20",
            "studyFirstSubmitQcDate": "2023-02-20",
            "studyFirstPostDateStruct": {
                "date": "2023-02-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-07",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "ReCode Therapeutics",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is the first-in-human study with RCT1100 and is designed to provide initial safety and tolerability data for future clinical studies.",
            "detailedDescription": "The primary objective of this study is to assess the safety and tolerability of a single ascending dose of inhaled RCT1100 administered via nebulizer to healthy participants and patients with Primary Ciliary Dyskinesia caused by a pathogenic mutation in the DNAI1 Gene."
        },
        "conditionsModule": {
            "conditions": [
                "Primary Ciliary Dyskinesia"
            ],
            "keywords": [
                "Primary Ciliary Dyskinesia",
                "PCD",
                "Kartagener Syndrome"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 9,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "RCT1100",
                    "type": "EXPERIMENTAL",
                    "description": "Drug: RCT1100 single dose",
                    "interventionNames": [
                        "Drug: RCT1100"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "RCT1100",
                    "description": "RCT1100 mRNA therapy supplied as varying dose strengths administered via oral inhalation using nebulizer",
                    "armGroupLabels": [
                        "RCT1100"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "The number of participants with Adverse Events (AEs) and Serious Adverse Events (SAEs).",
                    "description": "Safety and tolerability as assessed by number of participants with Adverse Events (AEs) and Serious Adverse Events (SAEs), as well as an adverse event of special interest (AESI): \"Fever\", which will include body temperature and any associated symptoms (chills, myalgia).",
                    "timeFrame": "From Baseline Through Day 180"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Major Inclusion Criteria:\n\n* Healthy, adult, male or female of, 18-65 years of age, inclusive, at screening.\n* Participant has pathogenic mutations in the DNAI1 gene\n* The participant has a forced expiratory volume in one second (FEV1) of at least 50% predicted.\n\nMajor Exclusion Criteria:\n\n* History or presence of clinically significant medical, surgical, clinical laboratory, or psychiatric condition or disease.\n* History of cancer, with exception of adequately treated basal cell or squamous cell carcinoma of the skin.\n* Medically significant hemoptysis\n* Anticoagulation therapy for the treatment of a pulmonary embolus or has had a pulmonary embolus in the last 6 months of screening.\n* Active tuberculosis infection.\n* Laboratory abnormalities in clinical laboratory tests at screening:\n\n  1. Serum creatinine level\n  2. Total bilirubin, aspartate aminotransferase or alanine aminotransferase values\n  3. Hematological or coagulation values outside the normal reference range\n* Any medical history of disease that has the potential to cause a rise in total bilirubin over the ULN\n* History of alcohol abuse or drug addiction with the last year of screening.\n* Active smoker (vaping included).\n\nOther protocol defined inclusion/exclusion criteria may apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Priya Ryali, MBA",
                    "role": "CONTACT",
                    "phone": "650-629-7900",
                    "email": "clinicaltrials@recodetx.com"
                },
                {
                    "name": "Cathy Vo Buu",
                    "role": "CONTACT",
                    "phone": "650-629-7900",
                    "email": "clinicaltrials@recodetx.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "John Matthews, MBBS, MCRP, PhD",
                    "affiliation": "ReCode Therapeutics, Inc.",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "PPD - Las Vegas Research Unit",
                    "status": "RECRUITING",
                    "city": "Las Vegas",
                    "state": "Nevada",
                    "zip": "89113",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "877-362-2608"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.17497,
                        "lon": -115.13722
                    }
                },
                {
                    "facility": "University of Pennsylvania",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Macquarie University",
                    "status": "RECRUITING",
                    "city": "Sydney",
                    "state": "New South Wales",
                    "zip": "2109",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.86785,
                        "lon": 151.20732
                    }
                },
                {
                    "facility": "New Zealand Clinical Research",
                    "status": "COMPLETED",
                    "city": "Auckland",
                    "country": "New Zealand",
                    "geoPoint": {
                        "lat": -36.84853,
                        "lon": 174.76349
                    }
                },
                {
                    "facility": "Royal Brompton Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "SW3 6NP",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002925",
                    "term": "Ciliary Motility Disorders"
                },
                {
                    "id": "D000020820",
                    "term": "Dyskinesias"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009069",
                    "term": "Movement Disorders"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000010038",
                    "term": "Otorhinolaryngologic Diseases"
                },
                {
                    "id": "D000072661",
                    "term": "Ciliopathies"
                },
                {
                    "id": "D000000015",
                    "term": "Abnormalities, Multiple"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M6164",
                    "name": "Ciliary Motility Disorders",
                    "asFound": "Primary Ciliary Dyskinesia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22574",
                    "name": "Dyskinesias",
                    "asFound": "Dyskinesia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10647",
                    "name": "Kartagener Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M12029",
                    "name": "Movement Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12961",
                    "name": "Otorhinolaryngologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M1076",
                    "name": "Ciliopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M14",
                    "name": "Abnormalities, Multiple",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "T4687",
                    "name": "Primary Ciliary Dyskinesia",
                    "asFound": "Primary Ciliary Dyskinesia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3205",
                    "name": "Kartagener Syndrome",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC09",
                    "name": "Ear, Nose, and Throat Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}